Results 111 to 120 of about 31,287 (200)

Therapeutic Role of Hydroxyurea in Paediatric Hydroxyurea Pertussis: A systematic review.

Sultan Qaboos University medical journal
This systematic review indicates that hydroxyurea may be a promising pharmacologic option for leukoreduction in paediatric critical pertussis. In reported cases, hydroxyurea was associated with leukocyte reduction and short-term survival. Its ability to potentially reduce the need for invasive leukoreductive procedures is especially relevant in ...
Alhamoud, Abdullah H., Suhaqi, Mohammed Y., Arishi, Qasem A., Somili, Fahd Y., Gohal, Hassan M., Almalki, Abdulaziz S., Eidoh, Mohammed A., Hazazi, Fadhel Y.   +7 more
openaire   +2 more sources

Initial low and moderate dose of hydroxyurea has a durable impact on primary stroke prevention in low-income settings. [PDF]

Blood Adv
Abdullahi SU, Galadanci NA, Bello-Manga H, Ibrahim UA, Jibir BW, Yusuf AH, Galadanci JA, Rodeghier M, DeBaun MR.   +8 more
europepmc   +1 more source

Sustainment of Hydroxyurea Adherence in Patients With Sickle Cell Disease.

JAMA Netw Open
Heitzer AM, Wooten Z, Luo G, Treadwell M, King AA, Gordeuk VR, Shah N, Abrams CM, McCuskee S, Gollan S, Longoria J, Hankins JS, Sickle Cell Disease Implementation Consortium.   +12 more
europepmc   +1 more source

Thrombotic burden and longitudinal outcomes in Thai patients with polycythemia vera. [PDF]

Ann Med
Hantrakun N, Tantiworawit A, Norasetthada L, Rattarittamrong E, Chai-Adisaksopha C, Rattanathammethee T, Hantrakool S, Piriyakhuntorn P, Punnachet T, Srichairatanakool S, Niprapan P.   +10 more
europepmc   +1 more source

Hydroxyurea in Sickle Cell Disease: Coagulation and Activation in an Observational Study. [PDF]

Clin Med Insights Pediatr
Borhany M, Iqbal HT, Abid M, Zafar S.
europepmc   +1 more source

Acute kidney injury: incidence, risk factors, and early outcomes in hospitalized children with sickle cell disease attending a tertiary hospital in Eastern Uganda. [PDF]

BMC Pediatr
Mohamed AW, Hassan HA, Ndeezi G, Dick I, Farah AA, Mohamed SA, Omar NA, Matan MO, Karshe AH, Araye FA, Mahamed NW, Mohamed JW, Elfakey W, Patrick KK.   +13 more
europepmc   +1 more source

Consensus on the use of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: a modified Delphi survey. [PDF]

Int J Hematol
Shimoda K, Takenaka K, Kitamura H, Dohi K, Yoshimoto R, Kirito K.   +5 more
europepmc   +1 more source

Retraction of "Heteroatom (B, N, P, and S)-Doped Cyclodextrin as a Hydroxyurea (HU) Drug Nanocarrier: A Computational Approach". [PDF]

ACS Omega
Afahanam LE, Louis H, Benjamin I, Gber TE, Ikot IJ, Manicum AE.   +5 more
europepmc   +1 more source

A KMT2C loss-of-function mutation in a JAK2-negative polycythemia vera-like myeloproliferative neoplasm: a case report. [PDF]

Front Oncol
Musa TN, Al Khateeb J, Sajdieh Y, Abualia NM, Karama A.   +4 more
europepmc   +1 more source

Pseudotumor Cerebri Syndrome and Essential Thrombocythemia: A Case Report. [PDF]

Clin Case Rep
Chang FT, Chen YY, Lin FY.
europepmc   +1 more source